A Mix of S and ΔS Variants of STAT3 Enable Survival of Activated B-Cell-Like Diffuse Large B-Cell Lymphoma Cells in Culture

Oncogenesis - United States
doi 10.1038/oncsis.2015.44
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Ets1 Positively Regulates Faim3 in Activated B Cell-Like (Abc) Diffuse Large B Cell Lymphoma (Dlbcl)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Bone Marrow Molecular Markers Associated With Relapsed/Refractory Activated B-Cell-Like Diffuse Large B-Cell Lymphoma

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2018English

Diffuse Large B-Cell Lymphoma

2020English

The Proportion of Activated B-Cell Like Subtype Among De Novo Diffuse Large B-Cell Lymphoma Increases With Age

Haematologica
Hematology
2011English

B-Cell Receptor Signaling in Diffuse Large B-Cell Lymphoma

Seminars in Hematology
Hematology
2015English

Diffuse Large B-Cell Lymphoma Presenting With Cholecystitis-Like Symptoms

Korean Journal of Clinical Oncology
2018English

Molecular Pathogenesis of Diffuse Large B-Cell Lymphoma

Seminars in Diagnostic Pathology
Forensic MedicinePathology
2011English

Inhibition of the STAT3 Target SGK1 Sensitizes Diffuse Large B Cell Lymphoma Cells to AKT Inhibitors

Blood Cancer Journal
OncologyHematology
2019English

Chronic Active B-Cell-Receptor Signalling in Diffuse Large B-Cell Lymphoma

Nature
Multidisciplinary
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy